Terms: = Bone cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
30 results:
1. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
[TBL] [Abstract] [Full Text] [Related]
2. Efficient diagnosis of hematologic malignancies using bone marrow microscopic images: A method based on MultiPathGAN and MobileViTv2.
Yang G; Qin Z; Mu J; Mao H; Mao H; Han M
Comput Methods Programs Biomed; 2023 Jul; 237():107583. PubMed ID: 37167882
[TBL] [Abstract] [Full Text] [Related]
3. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
4. ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
Fishman H; Madiwale S; Geron I; Bari V; Van Loocke W; Kirschenbaum Y; Ganmore I; Kugler E; Rein-Gil A; Friedlander G; Schiby G; Birger Y; Strehl S; Soulier J; Knoechel B; Ferrando A; Noy-Lotan S; Nagler A; Mulloy JC; Van Vlierberghe P; Izraeli S
Blood; 2022 Jan; 139(3):399-412. PubMed ID: 34624096
[TBL] [Abstract] [Full Text] [Related]
5. Ajuba transactivates N-cadherin expression in colorectal cancer cells through interaction with Twist.
Wu Z; Zou X; Xu Y; Zhou F; Kuai R; Li J; Yang D; Chu Y; Peng H
J Cell Mol Med; 2021 Aug; 25(16):8006-8014. PubMed ID: 34173718
[TBL] [Abstract] [Full Text] [Related]
6. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT
Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905
[TBL] [Abstract] [Full Text] [Related]
7. Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease.
Zhu S; Qiu H; Bennett S; Kuek V; Rosen V; Xu H; Xu J
Cell Mol Life Sci; 2019 Nov; 76(22):4493-4502. PubMed ID: 31317206
[TBL] [Abstract] [Full Text] [Related]
8. The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.
Zhang W; Duan N; Zhang Q; Song T; Li Z; Chen X; Wang K
Int J Biol Sci; 2018; 14(14):2023-2036. PubMed ID: 30585266
[TBL] [Abstract] [Full Text] [Related]
9. Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/ep300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer.
Xiang Q; Wang C; Zhang Y; Xue X; Song M; Zhang C; Li C; Wu C; Li K; Hui X; Zhou Y; Smaill JB; Patterson AV; Wu D; Ding K; Xu Y
Eur J Med Chem; 2018 Mar; 147():238-252. PubMed ID: 29448139
[TBL] [Abstract] [Full Text] [Related]
10. GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma.
Luo J; Xia Y; Luo J; Li J; Zhang C; Zhang H; Ma T; Yang L; Kong L
Cancer Lett; 2017 Dec; 410():112-123. PubMed ID: 28947141
[TBL] [Abstract] [Full Text] [Related]
11. Inhibiting p53 Acetylation Reduces cancer Chemotoxicity.
Zheng S; Koh XY; Goh HC; Rahmat SAB; Hwang LA; Lane DP
Cancer Res; 2017 Aug; 77(16):4342-4354. PubMed ID: 28655792
[TBL] [Abstract] [Full Text] [Related]
12. Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-
Sunami Y; Araki M; Kan S; Ito A; Hironaka Y; Imai M; Morishita S; Ohsaka A; Komatsu N
J Biol Chem; 2017 Feb; 292(7):2815-2829. PubMed ID: 28053092
[TBL] [Abstract] [Full Text] [Related]
13. Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.
François S; Sen N; Mitton B; Xiao X; Sakamoto KM; Arvin A
J Virol; 2016 Oct; 90(19):8686-97. PubMed ID: 27440893
[TBL] [Abstract] [Full Text] [Related]
14. PPARγ signaling and emerging opportunities for improved therapeutics.
Wang S; Dougherty EJ; Danner RL
Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
Griffith M; Griffith OL; Krysiak K; Skidmore ZL; Christopher MJ; Klco JM; Ramu A; Lamprecht TL; Wagner AH; Campbell KM; Lesurf R; Hundal J; Zhang J; Spies NC; Ainscough BJ; Larson DE; Heath SE; Fronick C; O'Laughlin S; Fulton RS; Magrini V; McGrath S; Smith SM; Miller CA; Maher CA; Payton JE; Walker JR; Eldred JM; Walter MJ; Link DC; Graubert TA; Westervelt P; Kulkarni S; DiPersio JF; Mardis ER; Wilson RK; Ley TJ
Exp Hematol; 2016 Jul; 44(7):603-13. PubMed ID: 27181063
[TBL] [Abstract] [Full Text] [Related]
16. Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.
Moheimani F; Roth HM; Cross J; Reid AT; Shaheen F; Warner SM; Hirota JA; Kicic A; Hallstrand TS; Kahn M; Stick SM; Hansbro PM; Hackett TL; Knight DA
Int J Biochem Cell Biol; 2015 Nov; 68():59-69. PubMed ID: 26315281
[TBL] [Abstract] [Full Text] [Related]
17. Tip110 Regulates the Cross Talk between p53 and Hypoxia-Inducible Factor 1α under Hypoxia and Promotes Survival of cancer Cells.
Timani KA; Liu Y; Fan Y; Mohammad KS; He JJ
Mol Cell Biol; 2015 Jul; 35(13):2254-64. PubMed ID: 25939381
[TBL] [Abstract] [Full Text] [Related]
18. Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.
Xu X; Yu T; Shi J; Chen X; Zhang W; Lin T; Liu Z; Wang Y; Zeng Z; Wang C; Li M; Liu C
J Biol Chem; 2014 Mar; 289(13):8881-90. PubMed ID: 24532795
[TBL] [Abstract] [Full Text] [Related]
19. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
[TBL] [Abstract] [Full Text] [Related]
20. Cost-effectiveness of denosumab versus zoledronic acid in the management of skeletal metastases secondary to breast cancer.
Snedecor SJ; Carter JA; Kaura S; Botteman MF
Clin Ther; 2012 Jun; 34(6):1334-49. PubMed ID: 22578308
[TBL] [Abstract] [Full Text] [Related]
[Next]
